LAGUNA HILLS, Calif., April 3, 2024 /PRNewswire/ — Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that data will be highlighted in a Quickshot Scientific Session and poster presentation at the 25th…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
